RE: This is whats going on (IMO)16 Feb 2021 20:53
Another possible reason for the TU being held back:
We expect to receive feedback from the MHRA (Medicines and Healthcare products Regulatory Agency) on the Clinical Trial Application by February 2021. Dosing of first patients will commence when we have responded to that feedback and received approval to proceed. I look forward to updating the market on the detailed timing in due course."
Despite Covid taking centre stage right now, we may still be awaiting the green light from MHRA.